A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables-Reference-Cited by-同舟云学术

A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables

Published:2014-12 Issue:1 Volume:15 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Jiang Zhiwei,Song Yang,Shou Qiong,Xia Jielai,Wang William

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/1745-6215-15-500.pdf

Reference28 articles.

1. Boissel JP, Collet JP, Moleur P, Haugh M: Surrogate endpoints: a basis for a rational approach. Eur J Clin Pharmacol. 1992, 43: 235-244. 10.1007/BF02333016.

2. De Gruttola V, Clax P, DeMets DL, Downing GJ, Ellenberg SS, Friedman L, Gail MH, Prentice R, Wittes J, Zeger SL: Considerations in the evaluation of surrogate endpoint in clinical trials: summary of a National Institutes of Health workgroup. Control Clin Trials. 2001, 22: 485-502. 10.1016/S0197-2456(01)00153-2.

3. Chuang-Stein C, DeMasi R: Surrogate endpoints in AIDS drug development: current status. Drug Inform J. 1998, 32: 439-448.

4. Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001, 69: 89-95.

5. US Department of Health and Human Services: FDA: The Nation’s Premier Consumer Health Protection Agency. 2004, Washington DC: US Food and Drug Administration

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monte Carlo Simulation for Trial Design Tool;Principles and Practice of Clinical Trials;2022

2. Monte Carlo Simulation for Trial Design Tool;Principles and Practice of Clinical Trials;2020-11-27

3. Monte Carlo Simulation for Trial Design Tool;Principles and Practice of Clinical Trials;2020

4. Challenges and methodology in the incorporation of biomarkers in cancer clinical trials;Critical Reviews in Oncology/Hematology;2017-02

5. Technical Translational Analysis of Molecular Biomarker Data;Molecular Biological Markers for Toxicology and Risk Assessment;2016